Recent studies suggest that the use of Celexa (citalopram) by pregnant mothers may lead to an increased risk in their child developing severe, life-threatening congenital birth defects. The manufacturer is now facing a growing number of lawsuit from women who allege that drug-makers downplayed this risk information.
UPDATE: Celexa Lawsuit filed for Child’s Heart Defect
July 7, 2014 — Courthouse News reports that a federal judge has allowed a lawsuit to proceed against Forest Laboratories on behalf of a child who was born with severe birth defects. The girl was born in July 2011 with severe heart defects (atrioventricular canal defects). Click here to read more.
April 29, 2014 — The use of high-dose antidepressants in children aged 10-24 has been linked to at least a doubled increased risk of deliberate self-harm (suicidal) behavior, according to a study published in JAMA Internal Medicine. Click here to read more.
Febraury 27, 2014 — Celexa linked to higher cardiovascular risks and decline in cognitive function when doses above 30-mg per day are used to treat patients with Alzheimer’s. The use of Celexa was shown to sedate patients, which is increasingly being seen as a form of nursing home abuse. Click here to read more.
January 30, 2013 — Study links Celexa to life-threatening irregular heart rhythm. Click here to read more.
October 19, 2012 — A new study has linked Celexa to an increased risk of gastrointestinal bleeding, bleeding in the brain, and stroke. This increased risk could be especially significant for people with risk factors for bleeding, such as those taking blood-thinning medications (like Pradaxa or warfarin). Click here to read more.
Celexa is a medication used in the treatment of chronic depression that persists nearly every day and interferes with a person’s quality living. By balancing chemicals in the brain, Celexa helps in the treatment of anxiety and major depressive disorders in adults. However Celexa side effects may be linked to an increased risk of congenital birth defects in children whose mothers took the antidepressant while pregnant. The U.S. Food and Drug Administration issued a warning back in July 2006 that addressed the potential risks associated with taking antidepressants like Celexa during pregnancy.
Celexa Class Action Lawsuit Information
Law360 reported in March 2014 that Forest Laboratories, Inc., agreed to pay $7.7 – $10.4 million to resolve Celexa lawsuits centralized in a Multi-District Litigation (MDL). Lawsuits were filed on behalf of children who were prescribed Celexa “off-label” when it was only approved for adults. They accuse Forest Laboratories of misleading parents about the indications for Celexa.